For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Altimmune Inc (NASDAQ: ALT) closed the day trading at $5.57 down -0.36% from the previous closing price of $5.59. In other words, the price has decreased by -$0.36 from its previous closing price. On the day, 2.39 million shares were traded.
Ratios:
For a better understanding of ALT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.10 and its Current Ratio is at 13.10. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $18.
On November 12, 2024, UBS started tracking the stock assigning a Buy rating and target price of $26.UBS initiated its Buy rating on November 12, 2024, with a $26 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 19 ’24 when Drutz David sold 16,011 shares for $6.90 per share. The transaction valued at 110,547 led to the insider holds 41,958 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 21448.50 while its Price-to-Book (P/B) ratio in mrq is 3.26.
Stock Price History:
Over the past 52 weeks, ALT has reached a high of $11.50, while it has fallen to a 52-week low of $5.28. The 50-Day Moving Average of the stock is -17.06%, while the 200-Day Moving Average is calculated to be -20.69%.
Shares Statistics:
A total of 77.01M shares are outstanding, with a floating share count of 76.22M. Insiders hold about 1.03% of the company’s shares, while institutions hold 53.06% stake in the company.
